financetom
Business
financetom
/
Business
/
Veeva Systems, Amgen Collaborate to Further Streamline Clinical Trials
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Veeva Systems, Amgen Collaborate to Further Streamline Clinical Trials
Aug 28, 2025 5:29 AM

08:09 AM EDT, 08/28/2025 (MT Newswires) -- Veeva Systems ( VEEV ) said Thursday that has entered into a collaboration with Amgen ( AMGN ) to help the US drugmaker further advance clinical development.

Veeva ( VEEV ) said Amgen ( AMGN ) will use the Veeva Clinical Platform to support and identify efficiencies across the clinical trial process.

Financial terms of the collaboration were not disclosed.

Shares of Veeva ( VEEV ) were down more than 3% in recent Thursday premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Horace Mann Educators Q3 Core Earnings, Revenue Increase; Reaffirms 2024 Core EPS Guidance
Horace Mann Educators Q3 Core Earnings, Revenue Increase; Reaffirms 2024 Core EPS Guidance
Nov 5, 2024
05:54 AM EST, 11/05/2024 (MT Newswires) -- Horace Mann Educators ( HMN ) reported Q3 core earnings late Monday of $0.76 per diluted share, up from $0.44 a year earlier. Four analysts polled by Capital IQ expected $0.75. Revenue for the quarter that ended Sept. 30 was $412.1 million, up from $378.7 million a year earlier. Three analysts surveyed by...
JELD-WEN Holding's Q3 Adjusted Earnings, Revenue Decline; Full-Year Revenue Outlook Lowered
JELD-WEN Holding's Q3 Adjusted Earnings, Revenue Decline; Full-Year Revenue Outlook Lowered
Nov 5, 2024
05:34 AM EST, 11/05/2024 (MT Newswires) -- JELD-WEN Holding ( JELD ) reported Q3 adjusted earnings Monday of $0.32 per share, down from $0.53 a year earlier. Analysts polled by Capital IQ expected $0.40. Revenue for the quarter ended Sept. 28 was $934.7 million, compared with $1.08 billion a year earlier. Analysts polled by Capital IQ expected $990.6 million. The...
HighPeak Energy Q3 Earnings Increase, Revenue Declines
HighPeak Energy Q3 Earnings Increase, Revenue Declines
Nov 5, 2024
05:20 AM EST, 11/05/2024 (MT Newswires) -- HighPeak Energy ( HPK ) reported Q3 earnings late Monday of $0.35 per diluted share, up from $0.28 a year earlier. Two analysts polled by Capital IQ expected $0.23. Revenue for the quarter ended Sept. 30 was $271.6 million, compared with $345.6 million a year earlier. Three analysts polled by Capital IQ expected...
Coca-Cola Europacific Partners cuts annual sales forecast on weak Europe demand
Coca-Cola Europacific Partners cuts annual sales forecast on weak Europe demand
Nov 5, 2024
(Reuters) - Coca-Cola Europacific Partners, a bottling unit of Coca-Cola, lowered its annual sales forecast on Tuesday in response to reduced demand for beverages in Europe, as well as weakness in Indonesia linked to the Middle East conflict. Although demand for sodas has remained resilient, customers from lower income groups are becoming more cautious and opting to eat at home...
Copyright 2023-2026 - www.financetom.com All Rights Reserved